NCT04044742: A trial that was reported late by Sorrento Therapeutics, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04044742 |
|---|---|
| Title | A Phase 3 Placebo-controlled Study to Evaluate the Efficacy and Safety of Intra-articular Administration of Resiniferatoxin Versus Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis of the Knee |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 31, 2020 |
| Completion date | March 31, 2023 |
| Required reporting date | March 30, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Nov. 10, 2021 |
| Days late | None |